Geode Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Sell |
1,108,460
-197,531
| -15% | -$2.01M | ﹤0.01% | 2282 |
|
|
2025
Q1 | $7.29M | Buy |
1,305,991
+27,278
| +2% | +$152K | ﹤0.01% | 2473 |
|
|
2024
Q4 | $10.3M | Buy |
1,278,713
+5,200
| +0.4% | +$42K | ﹤0.01% | 2351 |
|
|
2024
Q3 | $13.1M | Buy |
1,273,513
+50,821
| +4% | +$521K | ﹤0.01% | 2220 |
|
|
2024
Q2 | $8.65M | Buy |
1,222,692
+311,059
| +34% | +$2.2M | ﹤0.01% | 2412 |
|
|
2024
Q1 | $12.5M | Buy |
911,633
+36,742
| +4% | +$505K | ﹤0.01% | 2190 |
|
|
2023
Q4 | $8.05M | Buy |
874,891
+54,444
| +7% | +$501K | ﹤0.01% | 2454 |
|
|
2023
Q3 | $4.96M | Buy |
820,447
+91,065
| +12% | +$551K | ﹤0.01% | 2646 |
|
|
2023
Q2 | $5.66M | Buy |
729,382
+421,960
| +137% | +$3.27M | ﹤0.01% | 2613 |
|
|
2023
Q1 | $1.75M | Buy |
307,422
+23,711
| +8% | +$135K | ﹤0.01% | 3091 |
|
|
2022
Q4 | $1.67M | Sell |
283,711
-597
| -0.2% | -$3.52K | ﹤0.01% | 3124 |
|
|
2022
Q3 | $909K | Sell |
284,308
-40,065
| -12% | -$128K | ﹤0.01% | 3435 |
|
|
2022
Q2 | $1.45M | Sell |
324,373
-254,449
| -44% | -$1.14M | ﹤0.01% | 3244 |
|
|
2022
Q1 | $3.09M | Sell |
578,822
-37,050
| -6% | -$198K | ﹤0.01% | 3041 |
|
|
2021
Q4 | $9.05M | Sell |
615,872
-35,352
| -5% | -$520K | ﹤0.01% | 2516 |
|
|
2021
Q3 | $13.6M | Buy |
651,224
+243,343
| +60% | +$5.09M | ﹤0.01% | 2240 |
|
|
2021
Q2 | $7.22M | Buy |
407,881
+71,418
| +21% | +$1.26M | ﹤0.01% | 2693 |
|
|
2021
Q1 | $8.24M | Buy |
336,463
+21,963
| +7% | +$538K | ﹤0.01% | 2492 |
|
|
2020
Q4 | $10.6M | Buy |
314,500
+174,895
| +125% | +$5.92M | ﹤0.01% | 2133 |
|
|
2020
Q3 | $3.49M | Buy |
139,605
+1,479
| +1% | +$37K | ﹤0.01% | 2590 |
|
|
2020
Q2 | $4.66M | Buy |
+138,126
| New | +$4.66M | ﹤0.01% | 2378 |
|